HIV, HBV and HCV in people who inject drugs and are placed on methadone maintenance therapy, Yangon, Myanmar.

Study on 2 drug treatment centres for people who inject drugs and are enrolled in methadone maintenance therapy

• From: Department for International Development
• Published: 21 December 2018

• Country: Burma
• Document Type: Journal Article
• Theme: Health
• Authors: Aye, N.S., Oo, M.M., Harries, A.D., Mon, M.M.

Abstract

Two drug treatment centres (DTCs) for people who inject drugs (PWID) and are enrolled in methadone maintenance therapy (MMT), Yangon, Myanmar.

Objective of the study: To determine, in PWID enrolled for MMT from 2015 to 2017, 1) testing uptake and results for human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV); 2) risk factors for infection; and 3) retention in care and risk factors for loss to follow-up (LTFU).

This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Citation

Aye NS, Oo MM, Harries AD, Mon MM, Hone S, Oo HN, Wan NMA. HIV, HBV and HCV in people who inject drugs and are placed on methadone maintenance therapy, Yangon, Myanmar. Public Health Action. 2018 Dec 21;8(4):202–10.

Links

HIV, HBV and HCV in people who inject drugs and are placed on methadone maintenance therapy, Yangon, Myanmar

Published 21 December 2018